High-content screening Raman spectroscopy (HCS-RS) of panitumumab-exposed colorectal cancer cells

The Analyst ◽  
2019 ◽  
Vol 144 (20) ◽  
pp. 6098-6107 ◽  
Author(s):  
Abdullah S. Mondol ◽  
Samir F. El-Mashtoly ◽  
Tatjana Frick ◽  
Klaus Gerwert ◽  
Jürgen Popp ◽  
...  

Label-free screening for cancer cells exposed to monoclonal antibody-based drugs using HCS-RS.

RSC Advances ◽  
2021 ◽  
Vol 11 (26) ◽  
pp. 16131-16141
Author(s):  
Manali Haniti Mohd-Zahid ◽  
Siti Nadiah Zulkifli ◽  
Che Azurahanim Che Abdullah ◽  
JitKang Lim ◽  
Sharida Fakurazi ◽  
...  

5-FU-PEGylated AuNPs-CD133 is designed to improve specific targeting of 5-FU against colorectal cancer cells which abundantly express CD133.


The Analyst ◽  
2020 ◽  
Vol 145 (17) ◽  
pp. 5878-5888
Author(s):  
Julia Gala de Pablo ◽  
David R. Chisholm ◽  
Carrie A. Ambler ◽  
Sally A. Peyman ◽  
Andrew Whiting ◽  
...  

Tracking of the accumulation, activation, degradation of a photosensitiser and cell response in live colorectal cancer single-cells using Raman spectroscopy.


2021 ◽  
Author(s):  
Romain Chautard ◽  
Laetitia Corset ◽  
Sajida Ibrahim ◽  
Céline Desvignes ◽  
Gilles Paintaud ◽  
...  

Structured abstract Background & aim: Resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer (CRC) is frequent and prognostic biomarkers are lacking. MicroRNAs (miR) are good candidates in this context. We aimed to characterize cetuximab and panitumumab exposure influence on miR expression in colorectal cancer cells to identify those regulating the EGFR pathway and implicated in resistance to treatment. Finally, we aimed to identify miR expression in serum of patients with advanced CRC treated with cetuximab or panitumumab. Results: Cetuximab and panitumumab exposure induced significant expression variations of 17 miR out of a miRnome panel of 752. Six of those miR interacted with at least one downstream element of the EGFR pathway. Conclusion: After the bioinformatics two-phase process, 5 miR rarely described before could be potential actors of anti-EGFR monoclonal antibody resistance: miR-95-3p, miR-139-5p, miR-145-5p, miR-429 and miR-1247-5p. In vivo, we detected the expression of miR-139-5p and miR-145-5p in serum of patients with metastatic CRC.


Hybridoma ◽  
2010 ◽  
Vol 29 (4) ◽  
pp. 305-310 ◽  
Author(s):  
Wei Chen ◽  
Feng Li ◽  
Zhi-Mou Xue ◽  
Hao-Rong Wu

2006 ◽  
Vol 14 (4) ◽  
pp. 215-223 ◽  
Author(s):  
Christoph Mamot ◽  
Reto Ritschard ◽  
Willy Küng ◽  
John W. Park ◽  
Richard Herrmann ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document